Skip to main content
SpringerLink
Log in

Decreased specific anti-elastase activity in the uninvolved skin of patients with psoriasis

  • Original Contributions
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Summary

Inhibitory activities against elastase, chymotrypsin and trypsin were studied in the fluid from experimentally developed suction blisters in the uninvolved skin of patients with psoriasis. These activities determined by spectrophotometry of specific synthetic low molecular weight substrates were compared with respective antiproteinase activities in sera of 32 patients with psoriatic lesions, ten patients in remission, and ten healthy volunteers. A marked reduction (29.2%) in the specific elastase inhibitory activity of blister fluid was found in patients with psoriasis when compared with normal subjects (p<0.05), since neither chymotrypsin nor trypsin inhibitory activities were altered. This reduction was despite about a 30% increase in the elastase inhibitory activity in the sera of these patients, which was related presumably to their increased activity of α1-proteinase inhibitor, the main serum antiserine proteinase inhibitor. A decreased blister fluid∶serum elastase inhibition ratio was shown in a large majority of patients with psoriasis, even in symptomless patients. The deficiency in specific elastase inhibitory activity of suction blister fluid was predominantly associated with early onset of psoriasis, guttate lesions and inactive lesions, skin involvement less than 20% of body surface, duration of relapse shorter than 2 months, and frequent relapses. These data indicate that the uninvolved skin of patients with psoriasis contains low concentrations of specific elastase tissue inhibitor, which deficiency might result in an excessive in vivo hydrolytic activity of neutrophil elastase released from migrating cells in the psoriatic skin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barszcz D, Zarebska Z, Glinska-Ferenz M, Jabłońska S, Tigalonowa M, Glinski W (1988) Alpha1-proteinase inhibitor in psoriasis: reduced activity in symptom-free patients and during flare. Arch Dermatol Res 280:198–206

    PubMed  Google Scholar 

  2. Bos JD (1988) The pathomechanisms of psoriasis: the skin immune system and cyclosporin. Br J Dermatol 118:141–155

    PubMed  Google Scholar 

  3. Boxer LA, Smolen JE (1988) Neutrophil granule constituents and their release in health and disease. Hematol Oncol Clin North Am 2:101–134

    PubMed  Google Scholar 

  4. Bray MA, McKearn-Smith C, Metz-Virca G (1987) Stimulated release of neutral proteinase elastase and cathepsin G from inflammatory rat polymorphonuclear leukocytes. Inflammation 11:23–37

    PubMed  Google Scholar 

  5. Briggaman RA, Schechter NM, Fraki J, Lazarus GS (1984) Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes J Clin Invest 78:1427–1431

    Google Scholar 

  6. Chang A, Schalkwijk J, Happle R, van der Kerkhof PCM (1990) Elastase-inhibiting activity in scaling skin disorders. Acta Derm Venereol (Stockh) 70:147–151

    Google Scholar 

  7. Christman JK, Silverstein AC, Acs G (1977) Plasminogen activators. In: Barrett AJ (ed) Proteinases in mammalian cells and tissues. North-Holland, Amsterdam, pp 91–115

    Google Scholar 

  8. Del Mar EG, Largman C, Brodrick J, Geokas M (1979) A sensitive new substrate for chymotrypsin. Anal Biochem 99:316–320

    PubMed  Google Scholar 

  9. Farber EM, Nall L, Strefling A (1985) Psoriasis: a disease of the total skin. J Am Acad Dermatol 12:150–156

    PubMed  Google Scholar 

  10. Feinstein G (1984) Physiological roles of protein inhibitors. J Protein Chem 3:131–141

    Google Scholar 

  11. Foster S, Ilderton E, Summerly R, Yardley HJ (1983) The level of phospholipase A2 activity is raised in the uninvolved epidermis of psoriasis. Br J Dermatol 108:103–105

    PubMed  Google Scholar 

  12. Fraki JE, Briggaman RA, Lazarus GS (1982) Uninvolved skin from psoriatic patients develops signs of involved psoriatic skin after being grafted onto nude mice. Science 215:685–687

    PubMed  Google Scholar 

  13. Fraki JE, Lazarus GS, Gilgor RS, Marchase P, Singer KH (1983) Correlation of epidermal plasminogen activator activity with disease activity in psoriasis. Br J Dermatol 108:39–44

    PubMed  Google Scholar 

  14. Fry L (1988) Psoriasis. Br J Dermatol 119:445–461

    PubMed  Google Scholar 

  15. Glinski W, Barszcz D, Janczura E, Zarebska Z, Jabłońska S (1984) Neutral proteinases and other neutrophil enzymes in psoriasis, and their relation to disease activity. Br J Dermatol 111:147–154

    Google Scholar 

  16. Glinski W, Jarzabek-Chorzelska M, Kuligowski M, Pierozynska-Dubowska M, Glinska-Ferenz M, Jabłońska S (1990) Basement membrane zone as a target for human neutrophil elastase in psoriasis. Arch Dermatol Res 282:506–511

    PubMed  Google Scholar 

  17. Greaves MW, Camp RDR (1988) Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: an integrated approach to inflammation of human skin. Arch Dermatol Res 280 [Suppl]:33–41

    PubMed  Google Scholar 

  18. Grondahl-Hensen J, Ralfkiaer E, Nielsen LS, Kristensen P, Frentz G, Dano K (1987) Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin. J Invest Dermatol 88:28–32

    PubMed  Google Scholar 

  19. Havemann K, Gramse M (1984) Physiology and pathophysiology of neutral proteinases of human granulocytes. Adv Exp Med Biol 167:1–20

    Google Scholar 

  20. Hendrick SJ, Silverman AK, Solomon AR, Headington JT (1988) Alpha1-antitrypsin deficiency associated with panniculitis. J Am Acad Dermatol 18:684–688

    PubMed  Google Scholar 

  21. Heng MCY, Suni G, Kloss BA (1986) Electron microscopic features in psoriatic patients with a1-antitrypsin deficiency. J Invest Dermatol 87:59–64

    PubMed  Google Scholar 

  22. Heng MCY, Suni G, Kloss BA, Craig S, Kuehn BS, Chase DG (1986) Significance and pathogenesis of basal keratinocyte herniations in psoriasis. J Invest Dermatol 87:362–366

    PubMed  Google Scholar 

  23. Isei T, Schubert C, Christophers E (1990) Monocyte-derived neutrophil-activating peptide (NAP/IL-8) has dose-related pro-inflammatory properties in normal human skin. Arch Dermatol Res 281:572

    Google Scholar 

  24. Janoff A (1985) Elastase in tissue injury. Annu Rev Med 36:207–216

    PubMed  Google Scholar 

  25. Janus ED, Phillips NT, Carrell RW (1985) Smoking, lung function and α1-antitrypsin deficiency. Lancet I:152–154

    Google Scholar 

  26. Kiistala V (1968) Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 50:129–135

    PubMed  Google Scholar 

  27. Klebanoff SJ, Vadas MA, Harlan JM (1986) Stimulation of neutrophils by tumor necrosis factor. J Immunol 136:4220–4225

    PubMed  Google Scholar 

  28. Lammers AM, van de Kerkhof PCM, Schalkwijk J, Mier PD (1986) Elastase, a marker for polymorphonuclear leukocytes in skin infiltrates. Br J Dermatol 115:181–186

    PubMed  Google Scholar 

  29. Lotti T, Bonan P, Panconesi E (1988) Epidermal plasminogen activator activity, tPA-dependent, is a marker of disease activity in psoriasis. J Invest Dermatol 90:86–87

    PubMed  Google Scholar 

  30. Mansbridge J, Knapp A, Strefling A (1984) Evidence for an alternate pathway of keratinocyte maturation in psoriasis from an antigen found in psoriatic but not normal epidermis. J Invest Dermatol 83:296–301

    PubMed  Google Scholar 

  31. Morioka S, Lazarus GS, Jensen PJ (1987) Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG. J Invest Dermatol 89:474–477

    PubMed  Google Scholar 

  32. Nakijimi K, Powers JC, Ashe BM, Zimmermann M (1979) Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. J Biol Chem 254:4027–4034

    PubMed  Google Scholar 

  33. Schalkwijk J, Lammers AM, Chang A, van de Kerkhof PCM, Mier PD (1988) An epidermal elastase inhibitor induced by spontaneous or experimental inflammation. J Invest Dermatol 91:376

    PubMed  Google Scholar 

  34. Schroder JM, Christophers E (1986) Identification of C5a des arg and an anionic neutrophil activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 87:53–58

    PubMed  Google Scholar 

  35. Schwartz LB, Riedel C, Caulfield JP, Wasserman SI, Austen KF (1981) Cell association of complexes of chymase, heparin proteoglycan and protein after degranulation by rat mast cells. J Immunol 126:2071–2075

    PubMed  Google Scholar 

  36. Starkey PM (1977) Elastase and cathepsin G; the serine proteinases of human neutrophil leukocytes and spleen. In: Barrett AJ (ed) Proteinases in mammalian cells and tissues. Elsevier/North Holland Biomedical Press, Amsterdam, pp 57–89

    Google Scholar 

  37. Tagami H, Ofuji S (1977) Characterization of leukotactic factor derived from psoriatic scale. Br J Dermatol 97:509–518

    PubMed  Google Scholar 

  38. Travis J, Johnson D (1981) Human alpha1-proteinase inhibitor. In: Colowick SP, Kaplan NO, Lorand L (eds) Methods in enzymology, vol. 80, part C. Academic Press, New York London Paris San Diego, pp 754–765

    Google Scholar 

  39. Travis J, Salvesen GS (1983) Human plasma proteinase inhibitors. Annu Rev Biochem 52:655–709

    PubMed  Google Scholar 

  40. Van de Kerkhof PCM, Lammers AM (1987) Intraepidermal accumulation of polymorphonuclear leukocytes in chronic stable plaque psoriasis. Dermatologica 174:224–227

    PubMed  Google Scholar 

  41. Wiedow O, Schroder JM, Christophers E (1990) Elafin: purification and characterization of a new elastase-specific proteinase inhibitor derived from psoriatic scales. Arch Dermatol Res 281:559

    Google Scholar 

  42. Witt I, Lill H (1984) Alpha1-proteinase inhibitor (alpha-1-antitrypsin). In: Bergmeyer HV (ed) Methods of enzymatic analysis, vol. 5. Verlag Chemie, Weinheim Deerfield Beach Basel, pp 448–455

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Warsaw School of Medicine, 82A Koszykowa Street, PL-02-008, Warsaw, Poland

    W. Glinski, M. Pierozynska-Dubowska, M. Glinska-Ferenz & S. Jabłońska

Authors
  1. W. Glinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Pierozynska-Dubowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Glinska-Ferenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Jabłońska
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glinski, W., Pierozynska-Dubowska, M., Glinska-Ferenz, M. et al. Decreased specific anti-elastase activity in the uninvolved skin of patients with psoriasis. Arch Dermatol Res 283, 224–229 (1991). https://doi.org/10.1007/BF01106106

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01106106

Key words

Search

Navigation